[go: up one dir, main page]

RU2005103787A - METHOD FOR EXPERIMENTAL MYOCARDIAL INFARCTION THERAPY - Google Patents

METHOD FOR EXPERIMENTAL MYOCARDIAL INFARCTION THERAPY Download PDF

Info

Publication number
RU2005103787A
RU2005103787A RU2005103787/14A RU2005103787A RU2005103787A RU 2005103787 A RU2005103787 A RU 2005103787A RU 2005103787/14 A RU2005103787/14 A RU 2005103787/14A RU 2005103787 A RU2005103787 A RU 2005103787A RU 2005103787 A RU2005103787 A RU 2005103787A
Authority
RU
Russia
Prior art keywords
myocardial infarction
experimental myocardial
infarction therapy
therapy
preparation
Prior art date
Application number
RU2005103787/14A
Other languages
Russian (ru)
Other versions
RU2288738C2 (en
Inventor
Евгений Данилович Гольдберг (RU)
Евгений Данилович Гольдберг
Александр Михайлович Дыгай (RU)
Александр Михайлович Дыгай
Вадим Вадимович Жданов (RU)
Вадим Вадимович Жданов
Лариса Александровна Ставрова (RU)
Лариса Александровна Ставрова
Тать на Ивановна Фомина (RU)
Татьяна Ивановна Фомина
Марк Борисович Плотников (RU)
Марк Борисович Плотников
Олег Ибрагимович Алиев (RU)
Олег Ибрагимович Алиев
Валентина Ивановна Масычева (RU)
Валентина Ивановна Масычева
Наталь Владимировна Сотникова (RU)
Наталья Владимировна Сотникова
Original Assignee
ГУ Научно-исследовательский институт фармакологииТомского научного центра Сибирского отделени Российской академии медицинских наук НИИ фармакологииТНЦ СО РАМН (RU)
ГУ Научно-исследовательский институт фармакологии Томского научного центра Сибирского отделения Российской академии медицинских наук НИИ фармакологии ТНЦ СО РАМН
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ГУ Научно-исследовательский институт фармакологииТомского научного центра Сибирского отделени Российской академии медицинских наук НИИ фармакологииТНЦ СО РАМН (RU), ГУ Научно-исследовательский институт фармакологии Томского научного центра Сибирского отделения Российской академии медицинских наук НИИ фармакологии ТНЦ СО РАМН filed Critical ГУ Научно-исследовательский институт фармакологииТомского научного центра Сибирского отделени Российской академии медицинских наук НИИ фармакологииТНЦ СО РАМН (RU)
Priority to RU2005103787/14A priority Critical patent/RU2288738C2/en
Publication of RU2005103787A publication Critical patent/RU2005103787A/en
Application granted granted Critical
Publication of RU2288738C2 publication Critical patent/RU2288738C2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Claims (1)

Способ экспериментальной терапии инфаркта миокарда, заключающийся во введении препарата, отличающийся тем, что в качестве препарата используют рекомбинантный человеческий гранулоцитарный колониестимулирующий фактор, который вводят подкожно в дозе 100 мкг/кг 1 раз в день в течение 5 дней.A method of experimental treatment of myocardial infarction, which consists in administering a preparation, characterized in that a recombinant human granulocyte colony stimulating factor is used as a preparation, which is administered subcutaneously at a dose of 100 μg / kg once a day for 5 days.
RU2005103787/14A 2005-02-14 2005-02-14 Method for carrying out experimental myocardial infarction therapy RU2288738C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2005103787/14A RU2288738C2 (en) 2005-02-14 2005-02-14 Method for carrying out experimental myocardial infarction therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2005103787/14A RU2288738C2 (en) 2005-02-14 2005-02-14 Method for carrying out experimental myocardial infarction therapy

Publications (2)

Publication Number Publication Date
RU2005103787A true RU2005103787A (en) 2006-07-20
RU2288738C2 RU2288738C2 (en) 2006-12-10

Family

ID=37028495

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2005103787/14A RU2288738C2 (en) 2005-02-14 2005-02-14 Method for carrying out experimental myocardial infarction therapy

Country Status (1)

Country Link
RU (1) RU2288738C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2367451C1 (en) * 2008-01-09 2009-09-20 Государственное Образовательное Учреждение Высшего Профессионального Образования "Нижегородская Государственная Медицинская Академия Росздрава" (Гоу Впо "Нижгма Росздрава) Regeneration stimulator for cardiac hystiocytes and their endocellular structures and methods of application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2226101C2 (en) * 2002-02-19 2004-03-27 Черноморцева Елена Станиславовна Method for restricting necrosis area at modeling coronaroocclusion myocardial infarction in animals at decreased antioxidant background
RU2245162C2 (en) * 2003-01-04 2005-01-27 Козлов Владимир Александрович Method for treating myocardial infarction

Also Published As

Publication number Publication date
RU2288738C2 (en) 2006-12-10

Similar Documents

Publication Publication Date Title
EP2105135A3 (en) Pharmaceutical compositions for treating cancer
JP2005537234A5 (en)
IL189546A0 (en) Therapy for the treatment of disease
EP2460522A3 (en) Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
TW200744636A (en) Combined treatment with and composition of 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitor and anti-cancer agents
RU2001128504A (en) Growth promoting compositions
UA107578C2 (en) COMBINED DIABETES THERAPY
PH12013500559A1 (en) Combination therapy for treating hcv infection
WO2010033884A3 (en) Method for the treatment of radiation-induced neutropenia by administration of a multi-pegylated granulocyte colony stimulating factor (g-csf) variant
IL175259A0 (en) Use of a deoxynojirimycin derivative or a pharmaceutically salt thereof
CA2632207C (en) Use of calcitonin for the treatment of ra
EA200800397A1 (en) TIZANIDINE COMPOSITIONS AND TREATMENT METHODS USING COMPOSITIONS
DE602004030048D1 (en) EFFICIENCY
RU2005103787A (en) METHOD FOR EXPERIMENTAL MYOCARDIAL INFARCTION THERAPY
RU2004139157A (en) METHOD FOR EXPERIMENTAL ENCEPHALOPATHY THERAPY
RU2005121104A (en) METHOD FOR EXPERIMENTAL CHRONIC TOXIC HEPATITIS THERAPY
MX2009006670A (en) Pharmaceutical composition using aliskiren and avosentan.
EA200601579A1 (en) PEPTIDE, IMPROVING THE RESISTANCE OF CAPILLARIES, PHARMACEUTICAL COMPOSITION ON ITS BASIS AND METHOD OF ITS APPLICATION
CA2469702A1 (en) Darifenacin for use in the treatment of urgency induced by overactive bladder
JP2007517775A5 (en)
RU2003124971A (en) METHOD FOR TREATING PATIENTS WITH NEUROTIC AND SOMATOFORM DISORDERS
WO2006138589A3 (en) Opioid receptor ligands
CA2576926A1 (en) Use of midostaurin for treating gastrointestinal stromal tumors
WO2005097174A3 (en) Uses of a combination of ghrelin and somatotropin for the treatment of cachexia
RU2012104666A (en) APPLICATION OF THE COMBINATION OF TERIFLUNOMIDE AND INTERFERON BETA FOR THE TREATMENT OF MULTIPLE SCLEROSIS

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20070215